La cadena de opciones muestra datos clave de las opciones de acciones de Ocean Biomedical a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Ocean Biomedical..

Ocean Biomedical (OTC:OCEA) Bolsa, Cadena de Opciones

Ocean Biomedical

Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACLS

AMKR

BHAT

BNAI

FLNC

GNPX

HLIT

LIXT

LSCC

NLSP

OCEA

PRLD

SGRY

SLQT

SLXN

TANH

VSTE

Lattice Semiconductor sorprende con un alza del 14,7% en el premercado. Descubre qué otras acciones están en movimiento.

Acciones de Lattice Semiconductor (LSCC) suben un 15%; 20 acciones que se mueven en el premercado

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

OCEAN BIOMEDICAL INC by Ocean Biomediacal, Inc.

Ocean Biomedical Inc

Ocean Protocol - United States Dollar

Ocean Biomedical Inc Warrants (14/02/2028)

Ocean Park High Income ETF

Ocean Park International ETF

Ocean Power Technologies, Inc. Common Stock

Ocean Power Technologies Inc

OCEAN SPRAY 4 PR by Ocean Spray Cranberries, Inc.

Ocean Spray Cranberries Inc

OCEAN THERMAL ENERGY CORP by Ocean Thermal Energy Corp.

Ocean Thermal Energy Corp

OceanFirst Financial Corp. - Common Stock

OceanFirst Financial Corp

OceanFirst Financial Corp. - Depositary Shares

OceanPal Inc

OceanTech Acquisitions I Corp

OceanTech Acquisitions I Corp Units (1 Ord Class A & 1 War)

OceanTech Acquisitions I Corp Warrants (12/05/2026)

OceanTech Acquisitions I Corp Class A

Oceana Group Ltd

OceanaGold Corp

OCEANAGOLD (PHILIPPINES) by OCEANAGOLD (PHILIPPINES) INC.

OceanaGold Philippines Inc

Oceaneering International, Inc. Common Stock

Oceaneering International Inc

OCEANIA HEALTHCARE LTD by Oceania Healthcare Ltd.

Oceania Healthcare Ltd

OCEANIC IRON ORE CORP NEW by Oceanic Iron Ore Corp.

Oceanic Iron Ore Corp

OCEANIC WIND ENERGY INC. by Oceanic Wind Energy Inc.

Oceanic Wind Energy Inc

On Monday, the U.S. and China agreed to a temporary reduction in most tariffs on each other&#8217;s goods, marking a considerable easing of trade tensions. As a result, major tech stocks caught in the trade war, such as Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), climbed more than 4% during the pre-market trading session.
What Happened: The world&#8217;s two largest economies have agreed to a 90-day suspension of &#8220;reciprocal&#8221; tariffs, reducing them from 125% to 10%.&nbsp;However, the U.S. will maintain its 20% tariffs on Chinese imports linked to fentanyl, keeping the overall tariff level on China at 30%, <a href="https://www.cnbc.com/2025/05/12/us-and-china-agree-to-slash-tariffs-for-90-days.html">reported </a>CNBC.
As per the joint statement, Beijing has also agreed to suspend or lift all non-tariff countermeasures imposed since April 2, including sanctions on certain U.S. companies and export restrictions on key minerals, <a href="https://www.scmp.com/economy/global-economy/article/3309975/china-us-reduce-majority-tariffs-after-first-round-trade-talks?module=top_story&amp;pgtype=homepage">as per</a> the South China Morning Post.
This development comes after intensive trade talks between U.S. and Chinese representatives in Switzerland, with U.S. Treasury Secretary Scott Bessent expressing satisfaction with the discussions, stating, &#8220;We had very productive talks&nbsp;and I believe that the&nbsp;venue, here in Lake Geneva,&nbsp;added great equanimity to what&nbsp;was a very positive process.&#8221;
"Neither side wants a decoupling,&#8221; emphasized Bessent. 
Both countries have signaled their commitment to ongoing dialogue on economic and trade policy. Earlier in the day, the official handle of the Chinese Embassy in the U.S. stated, &#8220;high-level meeting on economic and trade affairs were in-depth, candid and constructive,&#8221; citing Chinese Vice Premier He Lifeng.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a>
Why It Matters: The weekend talks in Geneva, Switzerland, marked the first formal negotiations between the two superpowers since U.S. President Donald Trump imposed new tariffs of 145% on China earlier this year. Trump had stated that he "might speak with Chinese President Xi Jinping" based on the outcome in Switzerland.
This agreement comes in the wake of renewed<a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war"> trade negotiations </a>between the two nations, as reported. The talks, described by U.S. officials and President Trump as a potential &#8220;reset,&#8221; aimed to reduce tariffs and reestablish more stable trade terms. 
Despite the diplomatic tone, deep-rooted differences remain, particularly around technology, subsidies, and market transparency. The outcome of these talks is critical not just for U.S.–China relations, but for global trade stability in the months ahead. 
Investors were encouraged by the news of the tariff relief. During the pre-market trading session, shares of Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) climbed above 4%, while Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Amazon Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) rose more than 6%. Meanwhile, Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) rose 3.5%.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45339953/apple-exec-says-iphone-users-are-ditching-google-search-now-chamath-palihaptiya-urges-the-tech-giant-to-stop-wait" target="_blank" rel="noreferrer noopener">Apple Executive Says iPhone Users Are Ditching Google — Now Chamath Palihaptiya Urges The Search Giant To Stop Waiting For Data And Start Fighting Models Like ChatGPT</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Economics

General

AAPL

AMZN

NVDA

TSLA

Apple, Amazon, Nvidia Rise In Monday Premarket As US, China Agree To 90-Day Tariff Truce: 'Neither Side Wants A Decoupling'

The CNN Money Fear and Greed index showed almost no change in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Friday.
U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 100 during the session ahead of trade talks between the US and Chinese officials.
Major indices on the US also closed lower last week, with the S&amp;P 500 falling about 0.5% and the Nasdaq down around 0.3%. The Dow also declined almost 0.2% in the week.
Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) reported better-than-expected earnings for the first quarter and announced a $750 million share buyback plan on Thursday. EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) reported wider-than-expected loss for the first quarter on Friday.
On the economic data front, U.S. initial jobless claims declined by 13,000 to 228,000 in the week ending May 3, compared to market estimates of 230,000. U.S. labor productivity in the nonfarm business sector declined by 0.8% during the first quarter compared to estimates of a 0.7% drop.
Most sectors on the S&amp;P 500 closed on a positive note, with real estate, consumer discretionary and energy stocks recording biggest gains on Friday. However, health care and communication services stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed lower by around 119 points to 41,249.38 on Friday. The S&amp;P 500 fell 0.07% to 5,659.91, while the Nasdaq Composite gained 0.01% at 17,928.92 during Friday's session.
Investors are awaiting earnings results from DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>), Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) and NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) today.
At a current reading of 61.6, the index was in the &#8220;Greed&#8221; zone on Friday, versus a prior reading of 61.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

Earnings

LYFT

SATS

Dow Falls Over 100 Points, Also Records Weekly Loss: Fear & Greed Index Remains In 'Greed' Zone

Prominent investor Ross Gerber recently shared that, in his view, Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) subsidiary Google-backed Waymo self-driving technology performs better than human drivers, hinting at growing pressure on ride-sharing and autonomous vehicle rivals.
What Happened: The CEO and co-founder of Gerber Kawasaki Wealth and Investment Management shared his experience on his X account after observing a Waymo vehicle navigate through congested beach traffic. 
&#8220;A Waymo navigated by us with precision that was better than a human. Waymos drive extremely well,&#8221; Gerber stated, adding that this development &#8220;is going to be very tough competition&#8221; for Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Elon Musk&#8216;s Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
Gerber&#8217;s comments came in response to CBS Sunday Morning correspondent David Pogue&#8216;s segment highlighting Waymo&#8217;s achievement of 50 million miles driven without a fatality. According to Pogue&#8217;s report, Waymo plans expansion to 15 cities by year-end, offering rides at the &#8220;same price as Uber.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Yesterday in just packed beach traffic and horrid tourist drivers. A Waymo navigated by us with precision that was better than a human. Waymos drive extremely well. This is going to be very tough competition for uber and tesla. <a href="https://twitter.com/search?q=%24uber&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$uber</a> <a href="https://twitter.com/search?q=%24tsla&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$tsla</a> <a href="https://twitter.com/search?q=%24goog&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$goog</a> <a href="https://t.co/0VrfRYfYLM">https://t.co/0VrfRYfYLM</a>
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1921629990283530368?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45340216/openais-ipo-ambitions-hang-in-the-balance-as-microsoft-negotiates-equity-report">OpenAI&#8217;s IPO Ambitions Hang In The Balance As Microsoft Negotiates Equity: Report</a>
Why It Matters: The assessment from Gerber directly contradicts the position of prominent Tesla bull and Wedbush Securities analyst Dan Ives, who recently dismissed the Waymo and Toyota Motor Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) partnership as a <a href="https://www.benzinga.com/25/05/45126638/tesla-will-own-the-autonomous-market-dan-ives-says-shrugging-off-waymo-toyota-agreement">threat to Tesla&#8217;s autonomous ambitions</a>. &#8220;Tesla will own the autonomous market in my view and no one can compete with their scale and scope,&#8221; Ives posted, emphasizing Tesla&#8217;s upcoming Austin robotaxi launch in June as a &#8220;key chapter of growth.&#8221;
Waymo has established significant momentum in the autonomous vehicle race, recently announcing <a href="https://www.benzinga.com/25/04/45001569/waymo-announces-250000-weekly-paid-rides-across-four-us-cities-sundar-pichai-says-personal-ownership-an-option-in-the-future">it provides over 250,000</a> fully autonomous paid rides weekly across four major cities. 
The Alphabet subsidiary has formed a strategic partnership with Toyota to develop autonomous technology for personally owned vehicles, combining Waymo&#8217;s driving system expertise with Toyota&#8217;s manufacturing capabilities.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45339797/gary-black-doubles-down-on-ubers-autonomy-upside-reflects-on-tesla-debates-i-was-right-on-volume-pr-and-robotaxis">Gary Black Doubles Down On Uber&#8217;s Autonomy Upside, Reflects Debates With Tesla Faithful: &#8216;I Was Right&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Opinion

Tech

GOOG

GOOGL

UBER

Ross Gerber Calls Google-Backed Waymo's Self-Driving Taxis 'Better Than A Human,' Says They're 'Tough Competition' For Uber And Tesla

Economists have been predicting that retailers in the U.S. are likely to face pressure in the case of higher tariffs on China, as it is likely to &#8220;empty shelves&#8221; with a falling inventory-to-sales ratio.
What Happened: According to Torsten Slok, the chief economist at Apollo Academy, the inventory-to-sales ratio for retailers has fallen below the pre-pandemic level, sparking concerns about lower inventory as compared to the sales made by these retailers.
&#8220;The inventory-to-sales ratio for retailers was 1.5 before the pandemic, and now it is 1.3, see chart below,&#8221; the Apollo note stated.
Slok explained, &#8220;In other words, retailers will more quickly have empty shelves when goods no longer come in from China.&#8221;
This sentiment was also echoed by senior economist Mohamed El Erian in an X post. According to him, the ongoing high-level talks between China and the U.S. in Geneva, Switzerland, are likely to provide clarity on many concerns.
He highlights China&#8217;s &#8220;appetite for pain&#8221; and America&#8217;s fear of &#8220;empty shelves&#8221; as the primary matters that need to be solved via the ongoing talks.
&#8220;The outcome of this weekend's China-US tariff talks in Switzerland will be assessed in terms of what it reveals about China's appetite for pain, America's fear of &#8217;empty shelves,&#8217; and the way each country prioritizes the long-term objectives of trade policy. It will also be significant for many other countries, where there is already concern about the diversion of Chinese exports to their markets,&#8221; he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">An interesting week ahead for the global economy and markets, including on account of China-US tariff talks, the follow-up to the Federal Reserve policy meeting, and data: The outcome of this weekend's China-US tariff talks in Switzerland will be assessed in terms of what it…
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1921319822274523284?ref_src=twsrc%5Etfw">May 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45340465/bill-ackman-slams-subsidies-for-contributing-to-37-trillion-national-debt-hails-trumps-drug-price-order">Bill Ackman Slams Subsidies For Contributing To $37 Trillion National Debt, Hails Trump&#8217;s Drug Price Order</a>
Why It Matters: Over the weekend, the White House and Chinese officials signaled significant <a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war">headway in trade negotiations</a> held in Geneva.
Treasury Secretary Scott Bessent lauded the &#8220;substantial progress,&#8221; while Trade Ambassador Jamieson Greer highlighted the swift agreement, expressing optimism that the deal would address the U.S.&#8217;s $1.2 trillion trade deficit, a &#8220;national emergency.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: U.S. Announces China Trade Deal in Geneva <a href="https://t.co/JjgvYAvAGe">pic.twitter.com/JjgvYAvAGe</a>
&mdash; The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1921623939060519353?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
China&#8217;s Vice Commerce Minister Li Chenggang also announced an &#8220;important consensus,&#8221; predicting &#8220;good news for the world,&#8221; according to Reuters. Both sides indicated that details of this progress would be released on Monday.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell on Friday. The SPY was down 0.13% to $564.34, while the QQQ declined 0.066% to $487.97, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Monday, the futures of S&amp;P 500, Dow Jones and Nasdaq 100 were trading higher ahead of the pre-open.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45311562/mohamed-el-erian-flags-adverse-implications-for-domestic-industries-as-chinas-exports-rise-8-despite-21-drop-in-us-shipments" target="_blank" rel="noreferrer noopener">Mohamed El-Erian Flags ‘Adverse Implications' For Domestic Industries As China's Exports Rise 8% Despite 21% Drop In US Shipments</a></li>
</ul>
Photo: Orlowski Designs LLC/Shutterstock

Analyst Color

Government

Macro Economic Events

Market Summary

Regulations

Broad U.S. Equity ETFs

Futures

Analyst Ratings

ETFs

Economists Warn Of 'Empty Shelves' If Goods Stop Coming From China Amid Falling Inventory-To-Sales Ratio And Potential Tariffs

ACHC

ACHR

ACNT

AGEN

AIRJ

ALLT

ALTI

AMBC

AMPY

APEI

AQST

ARCT

ARWR

ASRT

ASYS

AUPH

BATRA

BATRK

Mobile Infrastructure Corporation Common Stock

BEEP

BETR

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLDE

BLNK

CATX

CEPU

CHGG

CHRS

CLLS

CLPR

CMCL

CMPO

CNNE

CNTY

CPSS

CTMX

CTRI

CWCO

DOLE

EDIT

EXOD

FGEN

FOXA

FRPH

FTEK

FTRE

GAIA

GETY

GPRO

GRDN

HBIO

HFFG

HNRG

IHRT

IMNN

INDI

ISPR

KBDC

KPTI

KSPI

LAND

LEGH

LINC

LSEA

LTBR

METC

Ramaco Resources, Inc. - Class B Common Stock

METCB

MFIC

MLNK

MLYS

MNDY

MODG

MRVI

MVIS

MVST

NMRA

NOTE

NPWR

NRGV

NRXS

Earnings Scheduled For May 12, 2025

On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the &#8220;<a href="https://www.benzinga.com/general/health-care/25/05/45339399/trump-says-prescription-drug-prices-set-to-drop-by-30-to-80-almost-immediately-thanks-to-most-favored-nation-plan-mark-cuban-urges-president-to-force-tran">most consequential executive order</a>&#8221; in U.S. history, aimed at lowering prescription drug prices.
What Happened: Trump said the executive order, set to be signed at 9 a.m. Monday, will implement a &#8220;Most Favored Nations&#8221; policy requiring pharmaceutical companies to charge U.S. consumers no more than the lowest price they offer for the same drug in any other country.
See More: <a href="https://www.benzinga.com/25/05/45338985/trump-reportedly-set-to-accept-flying-palace-from-qatar-white-house-says-lavish-gift-of-boeing-jumbo-jet-complies-with-all-applicable-laws">Trump Reportedly Set To Accept &#8216;Flying Palace&#8217; From Qatar, White House Says Lavish Gift Of Boeing Jumbo Jet Complies With &#8216;All Applicable Laws&#8217;</a>
Accusing pharmaceutical companies of overcharging American consumers, sometimes &#8220;five to ten times more&#8221; than patients in other countries, Trump slammed political opponents for enabling the status quo all these years.
Trump says that prescription drug prices will be reduced by &#8220;30% to 80%,&#8221; while rising throughout the world, to equalize and &#8220;bring fairness to America.&#8221;
Why It Matters: This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute outpatient prescriptions and biologicals, the prices for which are directly managed by the Centers for Medicare &amp; Medicaid Services (CMS).
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th class="has-text-align-center" data-align="center">Drug Name</th>
<th class="has-text-align-center" data-align="center">Manufacturer(s)</th>
<th class="has-text-align-center" data-align="center">Total Spending</th>
<th class="has-text-align-center" data-align="center">Primary Use</th>
</tr>
</thead>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Keytruda</td>
<td class="has-text-align-center" data-align="center">Merck &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>)</td>
<td class="has-text-align-center" data-align="center">$4.0B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Eylea</td>
<td class="has-text-align-center" data-align="center">Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) </td>
<td class="has-text-align-center" data-align="center">$3.4B</td>
<td class="has-text-align-center" data-align="center">Macular degeneration</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Prolia/Xgeva</td>
<td class="has-text-align-center" data-align="center">Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>)</td>
<td class="has-text-align-center" data-align="center">$2.1B</td>
<td class="has-text-align-center" data-align="center">Osteoporosis, bone metastases</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Opdivo</td>
<td class="has-text-align-center" data-align="center">Bristol-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) </td>
<td class="has-text-align-center" data-align="center">$2.0B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Darzalex</td>
<td class="has-text-align-center" data-align="center">Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>)</td>
<td class="has-text-align-center" data-align="center">$1.9B</td>
<td class="has-text-align-center" data-align="center">Multiple myeloma</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Avastin</td>
<td class="has-text-align-center" data-align="center">Roche Holdings AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>)</td>
<td class="has-text-align-center" data-align="center">$1.8B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">A breakdown of the top Medicare Part B drugs by spending in 2023, based on the latest data shared by the Centers for Medicare &amp; Medicaid Services (CMS).</figcaption></figure>
These are the stocks that are most likely to be hit by this announcement when markets open on Monday, given their sizable exposure to Medicare, especially being classified as Part B. 
According to a report by the Rand Corporation, a California-based policy think-tank, prescription drug prices in the U.S. are, on average, at least 2.78 times higher than other countries.
While Trump&#8217;s move is being criticized by the likes of crypto enthusiast Ed Krassenstein, calling it &#8220;just another Trump lie,&#8221; saying that an executive order can steer Medicare and Medicaid payments, but <a href="https://www.benzinga.com/general/health-care/25/05/45339399/trump-says-prescription-drug-prices-set-to-drop-by-30-to-80-almost-immediately-thanks-to-most-favored-nation-plan-mark-cuban-urges-president-to-force-tran">cannot force manufacturers</a> to cut prices. 
Others, such as billionaire investor Mark Cuban, have come out in support of the move, saying that it can &#8220;force transparency,&#8221; even if the President cannot force price cuts.
Drug pricing disparities have been a point of contention across the political spectrum. Recently, Novo Nordisk A/S&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) CEO, Lars Fruergaard Jorgensen, <a href="https://www.benzinga.com/general/biotech/24/09/40986953/novo-nordisk-ceo-to-face-senate-scrutiny-over-high-ozempic-and-wegovy-prices-hearing-scheduled-on">faced Senate scrutiny</a> on these vast differences, where he was targeted by Sen.&nbsp;Bernie Sanders&nbsp;(I-Vt.) for the high price of the company&#8217;s diabetes drug, Ozempic. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="135" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1024x135.png" alt="" class="wp-image-911404" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1024x135.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-300x40.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-768x101.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1536x202.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Novo Nordisk shares have an unfavorable price trend in the short, medium, and long term, but how does it compare with peers such as Johnson &amp; Johnson, Amgen, and Roche? Sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a> to find out.
Meanwhile, Novo Nordisk, Pfizer and J&amp;J were trading at least 3% lower in Monday premarket. 
Photo Courtesy: create jobs 51 On Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45339784/mohamed-el-erian-warns-us-china-deal-reveals-americas-fear-of-empty-shelves-as-markets-rally-on-trade-optimism-peter-schiff-skeptical-without-renminbi-revaluation">Mohamed El-Erian Warns US-China Deal Reveals &#8216;America&#8217;s Fear Of Empty Shelves&#8217; As Markets Rally On Trade Optimism, Peter Schiff Skeptical Without Renminbi Revaluation</a></li>
</ul>

Health Care

AMGN

REGN

RHHBY

Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket

The Federal Aviation Administration (FAA) is reportedly considering reducing the number of flights operating out of New Jersey's Newark Airport.
What Happened: The agency is set to meet with officials from several U.S. airlines to discuss scaling back flights out of Newark following disruptions caused by equipment malfunctions as well as staff shortages, CNBC reported <a href="https://www.cnbc.com/2025/05/11/newark-airport-flight-cuts-ahead-after-wee.html">on</a> Sunday.
"What you see in Newark is going to happen in other places across the country. It needs to be fixed," U.S. Transportation Secretary Sean Duffy said, according to the report.
Equipment outages caused air traffic controllers to lose communication as well as flight monitoring capabilities for over 90 seconds last month. There were also delays to over 1,000 flights due to equipment failures, the report suggests. The event also led to several staff members going on leave.
Questions have been raised over the aging air traffic infrastructure, which could reportedly cost over $31 billion to revamp, as well as more hiring of air traffic controllers, the report said.
"In ideal weather, with full staffing and with perfectly functioning technology, the FAA tells us that the airport (Newark) can only handle 77 flights per hour. And yet, the FAA regularly approves schedules of 80+ flights per hour almost every day between 3:00 pm and 8:00 p.m.," United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) CEO Scott Kirby told employees in a note, according to the report.
Why It Matters: The news comes in as the U.S. aviation industry is dealing with a difficult quarter, as analysts have<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45020724/airlines-face-significant-pressure-analysts-adjust-expectations-after-q1-results"> reset price targets </a>for several U.S. airlines following quarterly results.
American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) recently announced it was <a href="https://www.benzinga.com/25/04/44982328/american-airlines-flies-into-uncertainty-q1-revenue-miss-2025-outlook-pulled-but-debt-plan-on-track?_gl=1&#x2A;1yry3sk&#x2A;_gcl_au&#x2A;NTM5OTQ2NTE5LjE3NDcwMjQyNzY.&#x2A;_ga&#x2A;R1MyLjEuczE3NDcwMzM3NzAkbzIkZzEkdDE3NDcwMzM3NzAkajAkbDAkaDA.&#x2A;_ga_V7ZK73W7N0&#x2A;czE3NDcwMzM1MzkkbzMkZzEkdDE3NDcwMzQyNzAkajAkbDAkaDA.">pulling its 2025 outlook </a>as the airline's operating revenue declined slightly to $12.55 billion, a 0.15% YoY decline.
Elsewhere, JetBlue Airways Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) is reportedly in talks with United Airlines over a <a href="https://www.benzinga.com/25/04/45093263/jetblue-in-talks-with-united-airlines-over-possible-partnership-report">possible partnership</a> between the two companies.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/45035715/airbus-finalizes-deal-with-spirit-to-take-over-assets-paving-way-for-boeing-acquisition">Airbus Finalizes Deal With Spirit To Take Over Assets, Paving Way For Boeing Acquisition</a></li>
</ul>
Photo: Synthetic Messiah/Shutterstock

Politics

Travel

JBLU

FAA Mulls Cutting Flights At Newark Airport Amid Staffing Woes And Equipment Failures: Report

Eli Lilly and Company&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Zepbound demonstrated superior weight reduction compared to Novo Nordisk A/S&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy in a 72-week head-to-head trial.
What Happened: Participants treated with tirzepatide (Zepbound) achieved an average weight loss of 20.2%, compared to 13.7% with semaglutide (Wegovy), representing a 47% greater relative weight reduction, according to detailed results from a direct comparison trial published in The New England Journal of Medicine. 
On average, those taking Zepbound lost 50.3 pounds, while those on Wegovy lost 33.1 pounds over the course of the study.
The SURMOUNT-5 Phase 3b open-label clinical trial met its primary endpoint and all five key secondary endpoints, with Zepbound showing superiority across all weight reduction targets. Nearly 65% of Zepbound users achieved at least 15% weight loss compared to 40% on Wegovy, and participants experienced greater waist circumference reduction —7.2 inches versus 5.1 inches.
The safety profile aligned with previous trials, with primarily gastrointestinal-related adverse events that were generally mild to moderate in severity. Discontinuation rates due to adverse events were 6.1% for Zepbound versus 8% for Wegovy.
See Also: <a href="https://www.benzinga.com/25/05/45340117/peter-lynch-said-the-suckers-going-up-is-no-buy-strategy-suggests-two-things-to-look-for-in-a-company-that-suggest-something-different">Peter Lynch Once Lamented People Are &#8216;Careful&#8217; When They Buy A Fridge But Will &#8216;Drop Thousands&#8217; On A Stock Tip They Heard On A Bus</a>
Why It Matters: Zepbound&#8217;s performance in this direct comparison strengthens Lilly&#8217;s position in the rapidly growing weight loss medication market. The drug operates as a dual GIP and GLP-1 receptor agonist, compared to Wegovy, which works solely as a GLP-1 receptor agonist.
The U.S. Food and Drug Administration recently expanded Zepbound&#8217;s approval to include <a href="https://www.benzinga.com/news/25/01/42933134/fda-approves-weight-loss-drug-zepbound-for-sleep-apnea-will-insurance-cover-this-1000-per-month-medication">treatment for moderate-to-severe obstructive sleep apnea</a> in adults with obesity. Clinical trials showed patients experienced an average of 25 fewer breathing interruptions per hour, with up to 50% no longer exhibiting OSA symptoms after one year.
WW International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) recently announced a <a href="https://www.benzinga.com/news/25/04/45073094/weightwatchers-integrates-with-eli-lilly-to-expand-access-to-zepbound-stock-skyrockets-110">partnership with LillyDirect</a> pharmacy provider Gifthealth to simplify access to Zepbound for eligible self-pay clinic members. According to WeightWatchers, 33% of its clinic patients currently use Zepbound as part of their weight management plan, with prescriptions more than doubling in recent months.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45339966/bitcoin-creator-satoshi-nakamotos-estimated-wealth-crosses-bill-gates-amid-apex-cryptos-sharp-rebound">Bill Gates Left Behind By Satoshi Nakamoto: Bitcoin Creator&#8217;s Wealth Now Eclipses That Of Microsoft Co-Founder Amid Crypto&#8217;s Sharp Rebound</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial

Comments

Ocean Biomedical

Ocean Biomedical (OCEA) Opciones

Ocean Biomedical (OTC:OCEA) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL